Biliary Cancer
An open-label randomized trial of the efficacy and safety of zanidatamab with standard-of-care therapy against standard-of-care therapy alone for advanced HER2-positive biliary tract cancer (JZP598-302)
- Details
ClinicalTrials.gov ID:
NCT06282575
Diagnosis Type:
NA
USOR Number:
- Address
,
P: